Cargando…
Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation
BACKGROUND: Distal alveolar morphogenesis is marked by differentiation of alveolar type (AT)-II to AT-I cells that give rise to the primary site of gas exchange, the alveolar/vascular interface. Endothelial-Monocyte Activating Polypeptide (EMAP) II, an endogenous protein with anti-angiogenic propert...
Autores principales: | Chen, Yao, Legan, Susan K, Mahan, Anne, Thornton, Janet, Xu, Haiming, Schwarz, Margaret A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295640/ https://www.ncbi.nlm.nih.gov/pubmed/22214516 http://dx.doi.org/10.1186/1465-9921-13-1 |
Ejemplares similares
-
Cell Proliferation and Migration Are Modulated by Cdk-1-Phosphorylated Endothelial-Monocyte Activating Polypeptide II
por: Schwarz, Margaret A., et al.
Publicado: (2012) -
Hyperoxia inhibits alveolar epithelial repair by inhibiting the transdifferentiation of alveolar epithelial type II cells into type I cells
por: McKechnie, S, et al.
Publicado: (2008) -
Effects of Different Ligands in the Notch Signaling Pathway on the Proliferation and Transdifferentiation of Primary Type II Alveolar Epithelial Cells
por: Liu, Xiuxiang, et al.
Publicado: (2020) -
miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation
por: Moimas, Silvia, et al.
Publicado: (2019) -
Endothelial-Monocyte Activating Polypeptide Ii, a Novel Antitumor Cytokine That Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial Cells
por: Schwarz, Margaret A., et al.
Publicado: (1999)